ALLIGATE ANTIBIOTICS PRIVATE LIMITED
ALLIGATE ANTIBIOTICS PRIVATE LIMITED is a RAJASTHAN based PRIVATE LIMITED company, Registered at dated 04-NOV-2010 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of ALLIGATE ANTIBIOTICS PRIVATE LIMITED is U85110RJ2010PTC033267 and registration number is 033267.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies JAIPUR India. Authorized share capital of ALLIGATE ANTIBIOTICS PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in COMMUNITY, PERSONAL and SOCIAL SERVICES activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 2016-03-31 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2016-03-31.
ALLIGATE ANTIBIOTICS PRIVATE LIMITED has 2 directors VIKASH SHARMA, RINA SHARMA,
The registered Email address of ALLIGATE ANTIBIOTICS PRIVATE LIMITED is vikassharma4311@gmail.com and its registered address is JAIN MANDIR KE PASS,SALASAR STAND SIKAR RAJASTHAN INDIA 303904 RAJASTHAN RAJASTHAN india 303904.
The current status of ALLIGATE ANTIBIOTICS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
ALLIGATE ANTIBIOTICS PRIVATE LIMITED
JAIPUR
ACTIVE
COMMUNITY, PERSONAL and SOCIAL SERVICES
U85110RJ2010PTC033267
04 NOV 2010
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
2016-03-31
2016-03-31
CONTACT DETAILS
303904
INDIA
JAIN MANDIR KE PASS,SALASAR STAND SIKAR RAJASTHAN INDIA 303904
vikassharma4311@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
03288007 | VIKASH SHARMA | Director | 04/11/2010 |
03301802 | RINA SHARMA | Director | 04/11/2010 |
Details Updated by Companies
Quick Links
- All Registered company of RAJASTHAN
- Company Registered in RAJASTHAN
- All Registered company of JAIPUR in RAJASTHAN
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.